Hi #MedTwitter! Excited to be applying to #InternalMedicine for #Match2027! 🩺 I’m a @lebamericanuni #IMG from 🇱🇧, currently a research fellow studying cancer epigenomics & liquid biopsy @DanaFarber @harvardmed. AAMC ID: 14999066 Grateful for everyone who made this possible!

Our atlas of young-onset CRC is finally out in @NatureMedicine! We found a unique biology in younger patients that may explain the aggressive nature of this disease. This was a monumental effort with colleagues at @MassGenBrigham and @broadinstitute. @DFarberYoungCRC

Presenting rising star @RashadNawfal post-doc MD in our group working on novel liquid biopsy methods for non-invasive profiling of cancers! Come on down! #ESMO26 @DanaFarber_GU @DanaFarber Also applying for IM match! Don’t miss on him ! @OncoAlert @SylvanBacaLab #MattFreedman

Proud of our superstar fellow @elioibrahim8 presenting his work on clinical & transcriptomic correlates of primary resistance to nivo/ipi in metastatic RCC at #ESMO26! Important work toward understanding why some patients do not respond to immunotherapy! @myESMO @oncoalert

Our superstar postdoc @marc_eid presenting a novel liquid biospy approach for pancreatic cancer subtyping #MattFreedman @SylvanBacaLab @KarlSemaan Stay tuned for more ! #ESMO26 @myESMO @OncoAlert

Rising physician-scientist star in germline/cancer research @DanaFarber @mustafajsalehmd presents exciting findings at #ESMO26 identifying a germline IL7 variant linked to thyroid and joint immune-related toxicities across cancer types. @myESMO @OncoAlert @DanaFarber_GU @SashaGusevPosts

Heme/onc fellowship applicant @reneesaliby looks at mechanisms of resistance to nivolumab in older adults with mRCC. Individualized targeting of these pathways could help overcome resistance. @YaleIMed @DanaFarber @myESMO #ESMO26 @OncoAlert @DanaFarber_GU

Years of work in the making: superstar @BIDMChealth PGY2 @eddy_saad presents our work on the large R2000 cohort, focusing on rare genomic variants in ccRCC @DanaFarber @BraunMDPhD @VanAllenLab @esmo #ESMO26 @OncoAlert @DanaFarber_GU

Honored to be selected as one of this year’s #WorldGU26 poster competition winners! Excited to share our work and connect with colleagues across the #GUOncology community. Looking forward to a great meeting! @DrChoueiri @DanaFarber_GU @GUconference @IDEOlogyHealth

Our @DanaFarber own @sands_jacob changing Standard of Care in small cell lung cancer @myESMO #ESMO26 @OncoAlert

BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2026 #NobelPrize in Chemistry to Henri B. Kagan and Kenso Soai “for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis.”

BREAKING NEWS The 2026 #NobelPrize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”

Congratulations to our first #NobelPrize laureate of 2026 🎉 Early this morning Karl Deisseroth found out he was awarded this year's Nobel Prize in Physiology or Medicine. He seems very happy with the news!

Dr @WDKhatoun is a super star post-doc @DanaFarber_GU and every IM program would be lucky to have him ! @gungulati @SylvanBacaLab #FreedmanLab

I have really enjoyed working with Wassim on novel liquid biopsy technologies!

Congratulations to Drs. Nancy Lin, Kornelia Polyak, and Sara Tolaney on receiving @SusanGKomen research grants! Their work is advancing #BreastCancer research through new treatment targets, earlier detection, and innovative drug combinations. #BreastCancerResearch #DanaFarber @nlinmd @LabPolyak @stolaney1

Very excited to welcome four outstanding new faculty to the Lank Center for Genitourinary Oncology @DanaFarber 1) Dr. Nazli Dizman @NazliDizman 2) Dr. Brian Russell @brian_russell39 3) Dr. Hamid Emamekhoo @HamidEmamekhoo 4) Pr. Neeraj Agarwal @neerajaiims They bring complementary expertise spanning clinical investigation, microbiome science, informatics, quality improvement, education, and GU oncology. Hamid and Neeraj will also take on important broader institutional leadership roles @DanaFarber and @Harvard Cancer Consortium @df_hcc We are fortunate to have them—and the @DanaFarber_GU and our patients are in very good hands. Welcome to @CityOfBoston and @DanaFarber!

🎉Beyond thrilled to have joined and to be working with the incredible @DrChoueiri et al @DanaFarber! A very special thank you to @montypal for his tremendous mentorship and support! And many thanks to all the other mentors who have helped me along the way 🙏 😅 Looking back as a PGY-14, it only took two internal medicine residencies, a few research years, and an oncology fellowship to get here. But I enjoyed every bit of the journey and met so many incredible people!! @UniversiteEge @YaleIMed @UTMDAnderson @cityofhope @IMG_Oncologists @ASCOTECAG @ASCO @DanaFarber_GU @ConquerCancerFd @kureit @kidneycan @KidneyCancer

JUST IN: @FDA approves RAS inhibitor Daraxonrasib in pancreatic cancer. Our @DanaFarber own Dr Brian Wolpin presented the data @ASCO 2026 annual meeting !

Nineteen years ago, I joined Dana-Farber—with a little more hair and far fewer meetings! I’m deeply grateful to the patients who trusted me and to the colleagues, trainees, and teams who made this journey so meaningful. What a privilege—and what a ride!